Advertisement
Express Scripts to acquire EviCore Healthcare for $3.6B

Express Scripts to acquire EviCore Healthcare for $3.6B

By Alex Kacik  |  October 10, 2017

Pharmacy benefit manger Express Scripts will acquire medical benefits management company EviCore Healthcare for $3.6 billion, a move that will allow the company to access that growing market, the company said Tuesday.

Express Scripts to limit opioids; doctors concerned

Express Scripts to limit opioids; doctors concerned

By Associated Press  |  August 17, 2017

The American Medical Association says doctors and their patients, not pharmacy benefit managers, should determine opioid treatment plans, criticizing Express Scripts' plan to limit the number and strength of opioid drugs prescribed to first-time users.

Editorial: Tax reform is going nowhere

Editorial: Tax reform is going nowhere

By Merrill Goozner  |  August 07, 2017

In a rational political environment, there's a strong argument for tax reform—the next item on President Donald Trump's agenda. But we don't live in such an environment. Cutting taxes when the economy is near full employment will do nothing more than blow a massive hole in the federal budget.

Express Scripts' profit grows despite dwindling revenue from Anthem

By Alex Kacik  |  July 26, 2017

The largest pharmacy benefit manager in the country will lose Anthem's business in 2019, which is a sizable chunk of its business. For now, it's riding increasing specialty drug claims and home delivery revenue to an 11% second-quarter profit increase.

Blink Health ends Express Scripts contract over insulin program

Blink Health ends Express Scripts contract over insulin program

By Alex Kacik  |  June 14, 2017

Blink Health and Express Scripts partnered with Eli Lilly to provide up to a 40% discount on the drugmaker's insulin. An Express Scripts spokesman said Blink ended the contract because it did not want an exclusive relationship with the PBM, a violation of their agreement.

Editorial: The phony war on high drug prices

Editorial: The phony war on high drug prices

By Merrill Goozner  |  April 27, 2017

Politics, like nature, abhors a vacuum. Witness how the pharmaceutical industry has succeeded in taking advantage of President Donald Trump's failure to do something—anything—about high drug prices.

PBM Express Scripts loses biggest client Anthem

PBM Express Scripts loses biggest client Anthem

By Shelby Livingston  |  April 24, 2017

Express Scripts' shares plummeted more than 10% in the wake of the news that it lost its largest client. Anthem accounts for about 18% of the pharmacy benefit manager's revenue.

Report: Drug price increases were tame in 2016

By Adam Rubenfire  |  February 06, 2017

Per-person prescription drug spending increased 3.8% for health plans covering employees and their families, a tame increase when compared to the year before, according to a new report from Express Scripts.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print